Elevation Oncology Announces Clinical Cancer Research Publication Highlighting the Specific …,

Seribantumab is currently being clinically evaluated in the tumor-agnostic Phase 2 CRESTONE trial for patients with solid tumors harboring an NRG1 …, Seribantumab is currently being clinically evaluated in the tumor-agnostic Phase 2 CRESTONE trial for patients with solid tumors harboring an NRG1 …, Read More

Scroll to Top